ZNF571 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.836160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.070800E-01
Normal-vs-Stage2
1.408220E-01
Normal-vs-Stage3
9.297600E-02
Normal-vs-Stage4
4.876800E-01
Stage1-vs-Stage2
4.826000E-01
Stage1-vs-Stage3
5.361600E-02
Stage1-vs-Stage4
7.331000E-01
Stage2-vs-Stage3
1.223710E-04
Stage2-vs-Stage4
3.466400E-01
Stage3-vs-Stage4
5.062600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.021200E-01
Normal-vs-AfricanAmerican
1.183430E-01
Normal-vs-Asian
1.833770E-01
Caucasian-vs-AfricanAmerican
6.848200E-01
Caucasian-vs-Asian
5.649200E-01
AfricanAmerican-vs-Asian
9.792200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.044400E-01
Normal-vs-Female
1.638150E-01
Male-vs-Female
5.496600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.920600E-01
Normal-vs-Age(41-60Yrs)
2.796600E-01
Normal-vs-Age(61-80Yrs)
1.768830E-01
Normal-vs-Age(81-100Yrs)
1.581980E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.188000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.819200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.580100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.397400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.983800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.359390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.404300E-02
Normal-vs-Daily Drinker
2.301400E-01
Normal-vs-Weekly Drinker
2.934000E-02
Normal-vs-Occasional Drinker
3.082400E-01
Normal-vs-Social Drinker
3.557000E-01
Non Drinker-vs-Daily Drinker
5.644400E-01
Non Drinker-vs-Weekly Drinker
7.450200E-01
Non Drinker-vs-Occasional Drinker
1.538040E-01
Non Drinker-vs-Social Drinker
1.453980E-01
Daily Drinker-vs-Weekly Drinker
4.778400E-01
Daily Drinker-vs-Occasional Drinker
5.110200E-01
Daily Drinker-vs-Social Drinker
4.800200E-01
Weekly Drinker-vs-Occasional Drinker
1.369190E-01
Weekly Drinker-vs-Social Drinker
1.294240E-01
Occasional Drinker-vs-Social Drinker
9.203200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.043010E-01
Normal-vs-Grade 2
1.854120E-02
Normal-vs-Grade 3
9.857700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.314200E-01
Grade 1-vs-Grade 3
1.970830E-01
Grade 1-vs-Grade 4
1.043010E-01
Grade 2-vs-Grade 3
5.051600E-01
Grade 2-vs-Grade 4
1.854120E-02
Grade 3-vs-Grade 4
9.857700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.046620E-01
Normal-vs-NonDiabetic
1.882210E-01
Diabetic-vs-NonDiabetic
6.683200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.018400E-02
Normal-vs-NoPancreatitis
1.241050E-01
Pancreatitis-vs-NoPancreatitis
1.970440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.148600E-01
Normal-vs-N1
1.570380E-01
N0-vs-N1
7.034400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.763600E-01
Normal-vs-TP53-NonMutant
6.153600E-01
TP53-Mutant-vs-TP53-NonMutant
2.070400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
